-
The “HAZLO” project: A personalised cardiac rehabilitation programme
Globally, cardiovascular diseases (CVDs) account for approximately 50% of deaths from non-communicable diseases (NCDs) and are attributed a 10% global disease burden (DALY). Cardiac rehabilitation programmes aim at contributing to the recovery and secondary prevention of cardiac events, promote healthy behaviour, increase understanding of the new health condition and improve the psychosocial well-being of the…

-
MedeA: Clinical Implementation of a Pharmacogenetics Personalised Prescription System based on e-health in a European Regional Health Service
The MedeA (Medicina Personalizada Aplicada, Applied Personalised Medicine) Initiative is a genuine personalized medicine (PM) clinical implementation programme. It is based on an analysis of each patient’s individual pharmacogenetic biomarkers, drug-drug interactions and clinical data evaluated in an e-health strategy. This information is fed into a software system called Personalized oriented Prescription System (PoPS). It…

-
EP PerMed Information Event – Presentations online
11 June 2021 – The virtual Information Event “European Partnership for Personalised Medicine (EP PerMed) calling for national and regional involvement” organised by ICPerMed and ERA PerMed took place on May 31, 2021.
-
Sino-EU PerMed Workshop
8 June 2021 – Sino-EU PerMed invites to a workshop about Cooperation between China and Europe in Personalised Medicine. The results of a Sino-EU scientific and technological mapping and present best-practice examples for Sino-EU Cooperation will be presented. The workshop will be held in English and Chinese.
-
EP PerMed Information Sheets
27 May 2021 – In follow up of the “guidance document”, seven Information Sheets (download below) were developed by the ICPerMed and ERA PerMed “Preparatory Group”, comprising of four representatives of each initiative. The Information Sheets aim to promote the preparations of the European Partnership for Personalised Medicine (EP PerMed), which has been proposed to…
-
Update on the CSA Stars
20 May 2021 – The European Coordination and Support Action STARS (Strengthening Training of Academia in Regulatory Science) aims to improve the direct regulatory impact of results obtained in medical research. Their recent activities include a publication, a training course and an inventory on regulatory affairs.
-
PERSonalised mEdicine for Patients with Haemophilia and Other rare bleediNg disordErs – PERSEPHONE project
The objective of the project “PERSonalised mEdicine for Patients with Haemophilia and Other rare bleediNg disordErs” (PERSEPHONE) has been to implement a personalised approach for the optimal multidisciplinary care of haemophilic patients. The patient management pathway was re-designed based on a Value Based Healthcare (VBH) approach.

-
EP PerMed Information Day on May 31, 2021 – Registration is open
28 April 2021 – The initiatives ICPerMed and ERA PerMed invite all interested stakeholders, in particular national and regional authorities (as ministries, funders, etc.) to the virtual event “European Partnership for Personalised Medicine calling for national and regional involvement” to inform about ICPerMed and ERA PerMed’s proposal for EP PerMed, its objectives, activities and expected…
-
Save-the-date: EP PerMed Information Day on May 31, 2021
21 April 2021 – The initiatives ICPerMed and ERA PerMed invite all interested stakeholders, in particular national and regional authorities (as ministries, funders, etc.) to the virtual event “European Partnership for Personalised Medicine calling for national and regional involvement” to inform about ICPerMed and ERA PerMed’s proposal for EP PerMed, its objectives, activities and expected…
-
Review: Virtual ICPerMed Executive Committee Meeting on 23-24 February2021
15 April 2021 – On 23-24 February 2021, the ICPerMed Executive Committee met virtually to discuss and plan strategy and future activities of the consortium.